G266-1022 Screening compound: N-[7-(dimethylamino)-1,4-dimethyl-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-6-yl]-3,5-dimethoxybenzamide

G266-1022 Screening compound: N-[7-(dimethylamino)-1,4-dimethyl-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-6-yl]-3,5-dimethoxybenzamide
G266-1022 Screening compound: N-[7-(dimethylamino)-1,4-dimethyl-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-6-yl]-3,5-dimethoxybenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G266-1022
N-[7-(dimethylamino)-1,4-dimethyl-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-6-yl]-3,5-dimethoxybenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G266-1022

Molecular Formula

C21H24N4O5 (C21 H24 N4 O5)

Compound Name

N-[7-(dimethylamino)-1,4-dimethyl-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-6-yl]-3,5-dimethoxybenzamide

IUPAC name

N-[7-(dimethylamino)-14-dimethyl-23-dioxo-1234-tetrahydroquinoxalin-6-yl]-35-dimethoxybenzamide

SMILES

CN(C)c(c(NC(c1cc(OC)cc(OC)c1)=O)c1)cc(N(C)C2=O)c1N(C)C2=O

InChI

InChI=1S/C21H24N4O5/c1-23(2)16-11-18-17(24(3)20(27)21(28)25(18)4)10-15(16)22-19(26)12-7-13(29-5)9-14(8-12)30-6/h7-11H,1-6H3,(H,22,26)

InChI Key

PHLGKYQQJXDPFJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD09781000

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

412.45

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.197

Distribution Coefficient, logD

2.173

Water Solubility, LogSw

-2.78

Polar Surface Area

70.583

Acid Dissociation Constant (pKa)

8.65

Base Dissociation Constant (pKb)

2.41

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

G266-1022 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

Anticancer Library (62698 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with G266-1022 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G266-1022?
Check Price and Availability of G266-1022, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G266-1022 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G266-1022
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G266-1022
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G266-1022 available by request